4.4 Article

Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus

Journal

VIROLOGY
Volume 383, Issue 1, Pages 86-92

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2008.09.025

Keywords

Monkeypox virus; MPXV-ZAI-79; Graphiurus kelleni; Dormouse; Dryvax; Cidofovir; Smallpox; Variola

Categories

Funding

  1. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [R21-AI061512-01]
  2. NAID [U54-AI057160]
  3. Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MRCE)
  4. National Center for Research Resources (NCRR) of the NIH [T32RR007002]

Ask authors/readers for more resources

Suitable animal models are needed to study monkeypox virus (MPXV) as human monkeypox clinically resembles smallpox and MPXV is a zoonotic and potential bioterroristic agent. We have demonstrated that a species of African dormice, Graphiurus kelleni, is susceptible to a lethal infection of MPXV and that MPXV replicated in multiple organs of this species. Following intranasal administration, MPXV replicated locally in the nasal mucosa causing necrosis and hemorrhage with subsequent systemic spread to lymph nodes, spleen, liver, and other tissues where it caused severe necrosis and/or hemorrhage leading to death. The dormouse model was validated for testing prophylactic (Dryvax vaccine) and therapeutic (cidofovir) test articles against intranasal challenges with MPXV. (c) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available